Ultragenyx Pharmaceutical... (RARE)
undefined
undefined%
At close: undefined
43.60
2.30%
Pre-market Jan 07, 2025, 06:41 AM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11
Cash & Equivalents 213.58M 132.94M 307.58M 713.53M 433.58M 113.43M 100.49M 161.12M 93.57M 24.32M 7.43M 86.19M 10.64M
Short-Term Investments 363.63M 614.82M 432.61M 488.01M 321.65M 346.27M 134.00M 219.03M 343.43M 163.16M 45.95M n/a n/a
Long-Term Investments 199.90M 154.50M 293.86M 165.88M 32.93M 1.82M 9.97M 117.96M 99.26M n/a n/a n/a n/a
Other Long-Term Assets 57.69M 10.70M 11.62M -24.54M -4.19M 3.51M 3.41M -92.50M 2.73M 7.45M 3.10M 509.00K 417.00K
Receivables 73.39M 40.45M 28.43M 23.09M 32.84M 12.74M 5.17M n/a n/a n/a n/a n/a 103.00K
Inventory 33.97M 26.77M 16.23M 13.05M 11.55M 7.07M 757.00K n/a n/a n/a n/a n/a n/a
Other Current Assets 47.62M 68.93M 71.75M 57.63M 51.40M 42.86M 29.16M 21.55M 13.21M 11.86M 3.70M 255.00K 205.00K
Total Current Assets 732.18M 883.90M 856.60M 1.30B 851.02M 522.37M 244.47M 498.11M 450.21M 187.49M 55.23M 86.44M 10.95M
Property-Plant & Equipment 290.57M 285.69M 176.18M 114.04M 74.68M 20.05M 21.84M 17.05M 7.37M 3.03M 1.32M 1.36M 759.00K
Goodwill & Intangibles 210.68M 204.51M 175.19M 175.52M 173.41M 173.63M 185.95M n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 758.83M 661.54M 665.79M 464.25M 284.48M 197.19M 246.28M 42.52M 109.36M 10.48M 4.42M 1.87M 1.18M
Total Assets 1.49B 1.55B 1.52B 1.76B 1.14B 719.56M 490.75M 540.63M 559.57M 197.97M 59.65M 88.32M 12.13M
Account Payables 42.11M 43.27M 17.14M 12.92M 12.87M 12.28M 8.89M 5.36M 2.94M 4.86M 1.44M 1.20M 342.00K
Deferred Revenue n/a 1.48M 7.61M 59.22M n/a n/a 5.99M n/a n/a n/a n/a n/a n/a
Short-Term Debt 12.60M 23.56M 22.13M 17.95M 14.47M n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities 225.73M 192.90M 134.49M 140.85M 75.96M 62.45M 56.14M 54.90M 24.98M 7.66M 4.48M 1.99M 657.00K
Total Current Liabilities 280.44M 261.21M 181.37M 189.61M 103.30M 74.72M 71.01M 60.26M 27.92M 12.52M 5.92M 3.19M 999.00K
Long-Term Debt 30.57M 19.81M 382.69M 39.25M 29.76M n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities 904.59M 880.26M 1.00M 335.67M 315.37M 4.76M 5.12M 6.39M 561.00K 505.00K 3.62M 788.00K 487.00K
Total Long-Term Liabilities 935.16M 931.74M 418.47M 415.57M 378.43M 35.92M 36.28M 6.39M 561.00K 505.00K 3.62M 788.00K 487.00K
Total Liabilities 1.22B 1.19B 599.84M 605.18M 481.73M 110.65M 107.30M 66.65M 28.48M 13.02M 9.54M 3.98M 1.49M
Total Debt 43.17M 31.59M 41.97M 48.23M 36.99M n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock 82.00K 70.00K 69.00K 67.00K 58.00K 51.00K 44.00K 41.00K 39.00K 32.00K 4.00K 3.00K 3.00K
Retained Earnings -3.39B -2.78B -2.07B -1.62B -1.43B -1.03B -832.67M -530.53M -284.66M -139.04M -74.84M -27.06M -8.15M
Comprehensive Income 647.00K -6.57M -1.40M 689.00K -147.00K -633.00K -5.68M 905.00K -868.00K -174.00K 11.00K -353.00K -40.00K
Shareholders Equity 275.41M 352.49M 922.56M 1.15B 653.76M 608.91M 383.45M 473.97M 531.09M 184.94M 50.11M 84.34M 10.64M
Total Investments 563.53M 620.35M 726.47M 653.89M 354.57M 346.27M 143.98M 336.99M 442.69M 163.16M 45.95M n/a n/a